CD Pilcher, DA Wohl, CB Hicks, ES Daar, … - Annals of internal …, 2002 - Am Coll Physicians TO THE EDITOR: Daar and colleagues' (1) primary conclusion—that symptoms do not allow
focused screening for primary HIV infec- tion—may not be justified since “compatible
symptoms” in part determined inclusion in their study and performance of their gold ... Cited by 4 - Related articles - BL Direct - All 4 versions
[CITATION] Discontinuation of antiretroviral therapy commenced early in the course of HIV-1 …
M Markowitz, X Jin, A Hurley, V Simon, B Ramratnam, … - J Infect Dis, 2002 Cited by 3 - Related articles
[CITATION] Containment of SIV infection in vaccinated macaques: correlation with the …
A De Luca, ML Giancola, A Cingolani, A … - AIDS research and …, 2000 - liebertonline.com Page 1. AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 16, Number 9, 2000,
pp. 835–843 Mary Ann Liebert, Inc. Circulating Levels and ex Vivo Production of b
-Chemokines, Interferon g , and Interleukin 2 in Advanced Human ... Cited by 7 - Related articles - BL Direct - All 4 versions
- ►adisonline.com [PDF] SC Piscitelli, N Bhat, A Pau - Drug Safety, 2000 - ingentaconnect.com Abstract Immunomodulation has become a major focus of HIV research in an effort to
augment, boost or restore the patient's damaged immune system. Recombinant interleukin-2
is currently being studied in phase II/III trials in HIV-infected pa- tients. Several clinical ... Cited by 9 - Related articles - BL Direct - All 5 versions
[CITATION] Potent in vivo inhibition of HIV-1 infection in Thy/Liv-SCID-Hu mice after in vivo …
- ►nih.gov [PDF] M Allouche, Y Lunardi-Iskandar, C Varela- … - Clinical and …, 1990 - pubmedcentral.nih.gov SUMMARY We and others have shown that several T cell responses induced by the mitogen
phytohaemagglutinin (PHA), including T cell colony formation, IL-2 receptor (IL-2R)
expression, and IL-2 production are impaired in patients with AIDS and lymphadenopathy ... Cited by 3 - Related articles - All 4 versions
